Lipocalin-type and hematopoietic prostaglandin D synthases as a novel example of functional convergence

Prostaglandins and Other Lipid Mediators

Volumn 68-69, Issue , 2002, Pages 375-382

  Urade, Yoshihiro ^a   Eguchi, Naomi ^a  

^a JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

Author keywords

Trace; Allergy; Crystallographic structure; Gene knockout mice; Prostaglandin D2; Sleep; Transgenic mice

Indexed keywords

AMINO ACID; COMPLEMENTARY DNA; LIPOCALIN; PROSTAGLANDIN D SYNTHASE; ISOMERASE; PROSTAGLANDIN R2 D ISOMERASE; PROSTAGLANDIN R2 D-ISOMERASE;

AMINO ACID SEQUENCE; ARTICLE; CELLULAR DISTRIBUTION; CHROMOSOMAL LOCALIZATION; DNA ISOLATION; ENZYME STRUCTURE; GENE ISOLATION; HUMAN; KNOCKOUT MOUSE; MOLECULAR EVOLUTION; NONHUMAN; PROTEIN FUNCTION; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; X RAY CRYSTALLOGRAPHY; ANIMAL; CENTRAL NERVOUS SYSTEM; CHEMISTRY; ENZYMOLOGY; GENETICS; HEMATOPOIESIS; METABOLISM; PHYSIOLOGY; REVIEW; SLEEP;

ANIMALS; CENTRAL NERVOUS SYSTEM; HEMATOPOIESIS; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; SLEEP;

EID: 0036669560     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(02)00042-4     Document Type: Article

References (70)

1. 2 and sleep regulation. Biochim. Biophys. Acta. 1436:1999;606-615.
2. 2 in sleep-wake regulation - recent progress and perspectives. Neuroscientist. 8:2002;12-15.
3. Eguchi N.et al. Lack of tactile pain (allodynia) in lipocalin-type prostaglandin D synthase-deficient mice. Proc. Natl. Acad. Sci. USA. 96:1999;726-730.
4. Mizoguchi A.et al. Dominant localization of prostaglandin D receptors on arachnoid trabecular cells in mouse basal forebrain and their involvement in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA. 98:2001;11674-11679.
5. 2 by human helper T cell subsets. J. Immunol. 164:2000;2277-2280.
6. 2 as a mediator of allergic asthma. Science. 287:2000;2013-2017.
7. 2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J. Exp. Med. 193:2001;255-261.
8. 2 receptors CRTH2 and DP. J. Allergy Clin. Immunol. 108:2001;982-988.
9. Inoue H.et al. Feedback control of cyclooxygenase-2 expression through PPARγ J. Biol. Chem. 275:2000;28028-28032.
10. 2 inhibits multiple steps in the NF-kB signaling pathway. Proc. Natl. Acad. Sci. USA. 97:2000;4844-4849.
11. Urade Y., Hayaishi O. Prostaglandin D synthase: structure and function. Vitam. Horm. 58:2000;89-120.
12. Urade Y., Hayaishi O. Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandin D synthase. Biochim. Biophys. Acta. 1482:2000;259-271.
13. Pinzar E.et al. Prostaglandin D synthase gene is involved in the regulation of non-rapid eye movement sleep. Proc. Natl. Acad. Sci. USA. 97:2000;4903-4907.
14. Fujitani Y.et al. Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J. Immunol. 168:2002;443-449.
15. 2 and reproduction. J Reprod Immunol, in press.
16. Inui T.et al. Enhancement of lipocalin-type prostaglandin D synthase enzyme activity by guanidine hydrochloride. Biochem. Biophys. Res. Commun. 266:1999;641-646.
17. Saso L.et al. Changes in concanavalin A-reactive proteins in neurological disorders. J. Clin. Lab. Anal. 13:1999;158-165.
18. Grunewald S.et al. Beta-trace protein in human cerebrospinal fluid: a diagnostic marker for N-glycosylation defects in brain. Biochim. Biophys. Acta. 1455:1999;54-60.
19. Imbach T.et al. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie. J. Clin. Invest. 105:2000;233-239.
20. Manya H.et al. Comparative study of the asparagine-linked sugar chains of human lipocalin-type prostaglandin D synthase purified from urine and amniotic fluid, and recombinantly expressed in Chinese hamster ovary cells. J. Biochem. 127:2000;1001-1011.
21. Chico E., Jager V. Perfusion culture of baculovirus-infected BTI-Tn-5B1-4 insect cells: a method to restore cell specific beta-trace glycoprotein productivity at high cell density. Biotechnol. Bioeng. 70:2000;574-586.
22. Berryhill B.L.et al. Production of prostaglandin D synthase as a keratan sulfate proteoglycan by cultured bovine keratocytes. Invest. Ophthamol. Vis. Sci. 42:2001;1201-1207.
23. Angenstein F.et al. Age-dependent differences in glutamate-induced phosphorylation systems in rat hippocampal slices. Hippocampus. 9:1999;173-185.
24. Baeker R.et al. Lipocalin-type prostaglandin D synthase in milk: a new biomarker for bovine mastitis. Prostaglandins Other Lipid Mediat. 67:2002;75-88.
25. Melegos D.N.et al. Highly elevated levels of prostaglandin D synthase in the serum of patients with renal failure. Urology. 53:1999;32-37.
26. 2 synthase in ram and stallion epididymal fluids: origin and regulation. Biol. Reprod. 60:1999;558-566.
27. Borchert G.N.et al. Quantification of pepsinogen C and prostaglandin D synthase in breast cyst fluid and their potential utility for cyst type classification. Clin. Chem. 32:1999;39-44.
28. Diamandis E.P.et al. Seminal plasma biochemical markers and their association with semen analysis findings. Urology. 53:1999;596-603.
29. Priem F.et al. Beta-trace protein in serum: a new marker of glomerular filtration rate in the creatinine-blind range. Clin. Chem. 45:1999;567-568.
30. Mase M.et al. Acute and transient increase of lipocalin-type prostaglandin D synthase (beta-trace) level in cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage. Neurosci. Lett. 270:1999;188-190.
31. Giessing M. Beta-trace protein as indicator of glomerular filtration rate. Urology. 54:1999;940-941.
32. Sauter E.R.et al. Biological markers of risk in nipple aspirate fluid are associated with residual cancer and tumour size. Br. J. Cancer. 81:1999;1222-1227.
33. Urade Y.et al. Secretion of lipocalin-type prostaglandin D synthase (beta-trace) from human heart to plasma during coronary circulation. Adv. Exp. Med. Biol. 469:1999;49-54.
34. Gerena R.L.et al. Immunocytochemical localization of lipocalin-type prostaglandin D synthase in the bull testis and epididymis and on ejaculated sperm. Biol. Reprod. 62:2000;547-556.
35. Fouchecourt S.et al. Stallion epididymal fluid proteome: qualitative and quantitative characterization; secretion and dynamic changes of major proteins. Biol. Reprod. 62:2000;1790-1803.
36. Rodriguez C.M.et al. Expression of the lipocalin-type prostaglandin D synthase gene in the reproductive tracts of Holstein bulls. J. Reprod. Fertil. 120:2000;303-309.
37. Bachmann G.et al. Clinical experience with beta-trace protein as a marker for cerebrospinal fluid. Ann. Otol. Rhinol. Laryngol. 109:2000;1099-1102.
38. Inoue T.et al. Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Thromb. Haemost. 85:2001;165-170.
39. Hirawa N.et al. Urinary prostaglandin D synthase (β-trace) excretion increases in the early-stage of diabetes mellitus. Nephlon. 87:2001;321-327.
40. Bachmann G.et al. Traces of perilymph detected in epipharyngeal fluid: perilymphatic fistula as a cause of sudden hearing loss diagnosed with beta-trace protein (prostaglandin D synthase) immunoelectrophoresis. J. Laryngol. Otol. 115:2001;132-135.
41. Ishizuka M.et al. Inflammatory stimuli increase prostaglandin D synthase levels in cerebrospinal fluid of rats. Neuroreport. 12:2001;1161-1165.
42. Burkhard P.R. Assessing cerebrospinal fluid rhinorrhea: a two-dimensional electrophoresis approach. Electrophoresis. 22:2001;1826-1833.
43. Reiber H. Dynamics of brain-derived proteins in cerebrospinal fluid. Clin. Chem. Acta. 310:2001;173-186.
44. Petereit H.F. A new nephelometric assay for beta-trace protein (prostaglandin D synthase) as an indicator of liquorrhoea. J. Neurol. Neurosurg. Psychiatry. 71:2001;347-351.
45. Wait R.et al. Proteins of rat serum, urine, and cerebrospinal fluid. VI. Further protein identifications and interstrain comparison. Electrophoresis. 22:2001;3043-3052.
46. Hiraoka A.et al. Charge microheterogeneity of the beta-trace proteins (lipocalin-type prostaglandin D synthase) in the cerebrospinal fluid of patients with neurological disorders analyzed by capillary isoelectrofocusing. Electrophoresis. 22:2001;3433-3437.
47. Woitas R.P.et al. Low-molecular weight proteins as markers for glomerular filtration rate. Clin. Chem. 47:2001;2179-2180.
48. Priem F.et al. Beta-trace protein is not better than cystatin C as an indicator of reduced glomerular filtration rate. Clin. Chem. 47:2001;2181.
49. Hirawa N.et al. Lipocalin-type prostaglandin D synthase in essential hypertension. Hypertension. 39:2002;449-454.
50. Hamano K, et al. Blood sugar control reverses the increase in urinary excretion of prostaglandin D synthase in diabetic patients. Nephron, in press.
51. Beuckmann C.T.et al. Binding of biliverdin, bilirubin, and thyroid hormones to lipocalin-type prostaglandin D synthase. Biochemistry. 38:1999;8006-8013.
52. Beuckmann C.T.et al. Cellular localization of lipocalin-type prostaglandin D synthase (β-trace) in the central nervous system of the adult rat. J. Comp. Neurol. 428:2000;62-78.
53. 2 synthetase is a multifunctional molecule: its expression and regulation. Endocrinology. 141:2000;710-721.
54. Gerena R.L.et al. Stage and region-specific localization of lipocalin-type prostaglandin D synthase in the adult murine testis and epididymis. J. Androl. 21:2000;848-854.
55. 2 synthase in vascular endothelial cells. Circ. Res. 86:2000;967-973.
56. 2 synthase induces apoptosis in PC12 neuronal cells. Neuroreport. 12:2001;2623-2628.
57. 2 synthase induces apoptosis in pig kidney LLC-PK1 cells. Kidney Int. 60:2001;1692-1698.
58. Taniike M, et al. Perineuronal oligodendrocytes protect neuronal apoptosis through the production of lipocalin-type prostaglandin D synthase in a genetic demyelinating model. J Neurosci 2002;22:4885-96.
59. García-Fernández L.F.et al. Dexamethasone induces lipocalin-type prostaglandin D synthase gene expression in mouse neuronal cells. J. Neurochem. 75:2000;460-470.
60. Chabas D.et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 294:2001;1731-1735.
61. 2 synthase, a novel class sigma glutathione S-transferase. Biochem. J. 333:1998;317-325.
62. Matsushita N.et al. Pharmacological studies on the novel antiallergic drug HQL-79. I. Antiallergic and antiasthmatic effects in various experimental models. Jpn. J. Pharmacol. 78:1998;1-10.
63. Matsushita N.et al. Pharmacological studies on the novel antiallergic drug HQL-79. II. Elucidation of mechanisms for antiallergic and antiasthmatic effects. Jpn. J. Pharmacol. 78:1998;11-22.
64. Kanaoka Y.et al. Structure and chromosomal localization of human and mouse genes for hematopoietic prostaglandin D synthase. Conservation of the ancestral genomic structure of sigma-class glutathione S-transferase. Eur. J. Biochem. 267:2000;3315-3322.
65. 2 synthases. Biochem. J. 359:2001;507-516.
66. Pinzar E.et al. Structural basis of hematopoietic prostaglandin D synthase activity elucidated by site-directed mutagenesis. J. Biol. Chem. 275:2000;31239-31244.
67. 2. J. Biol. Chem. 276:2001;34918-34927.
68. Fujimori K.et al. Transcriptional activation of the human hematopoietic prostaglandin D synthase gene in megakaryoblastic cells. J. Biol. Chem. 275:2000;40511-40516.
69. 2-mediated manner. Mol Human Reprod 2002;8:181-7.
70. Okinaga T, et al. Induction of hematopoietic prostaglandin D synthase in hyalinated necrotic muscle fibers: Its implication in grouped necrosis. Acta Neuropathol, in press.